7.5.3. chemotherapy. chemotherapy alone rarely produces durable complete remissions. general, clinical complete response rate 56% reported series, must weighed staging error > 60% . response chemotherapy prognostic factor treatment outcome eventual survival although may confounded patient selection . several groups reported effect chemotherapy resectable tumours (neoadjuvant approach), well unresectable primary tumours . neoadjuvant chemotherapy two three cycles mvac cmv led down-staging primary tumour various prospective series . bladder-conserving strategy turb systemic cisplatin-based chemotherapy reported several years ago could lead long-term survival intact bladder highly selected patient population . recent large retrospective analysis u.s. national cancer database cohort reported 1,538 patients treated turb multi-agent chemotherapy . two 5-year os patients 49% 32.9% ct2 patients 52.6% 36.2%, respectively. data show longterm survival intact bladder achieved subset patients recommended routine use. 7.5.3.1. summary evidence guideline chemotherapy summary evidencelecomplete partial local responses reported cisplatin-based chemotherapy primary therapy locally-advanced tumours highly selected patients.2b recommendationstrength ratingdo offer chemotherapy alone primary therapy localised bladder cancer.strong